Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2026-03-30

FDA Approved: FOCINVEZ — Supplemental Application (Steriscience Specialties Private Limited)

View source ↗

Summary

The FDA approved a supplemental application for FOCINVEZ (fosaprepitant dimeglumine) submitted by Steriscience Specialties Private Limited.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • FOCINVEZ (fosaprepitant dimeglumine)

Snippet

SUPPL AP for FOCINVEZ (FOSAPREPITANT DIMEGLUMINE)